Results 191 to 200 of about 336,071 (238)

Monocyte-to-lymphocyte ratio as a predictor of outcomes in patients with hepatocellular carcinoma. [PDF]

Front Oncol
Zhou W, Xiong L, Li Z, Zhang Z, Yang J, Cao H.   +5 more
europepmc   +1 more source

Carbon Dots for Cancer Theranostics: Synthesis Strategies, Luminescence Properties, and Advances in Bioimaging‐Guided Diagnosis and Therapy

Chemistry – A European Journal, EarlyView.
Lighting up the path to precision oncology: This review comprehensively summarizes the rational design of carbon dots (CDs), elucidating how core size, surface chemistry, and heteroatom doping dictate their luminescence mechanisms. Special emphasis is placed on engineering NIR‐II emissive CDs for deep‐tissue imaging.
Zekun Yan, Yupeng Liu, Jinyun Tan, Songnan Qu   +3 more
wiley   +1 more source

Correction: Peptide‑based therapeutics targeting the SLC39A14‑PIWIL2 fusion in hepatocellular carcinoma. [PDF]

Genomics Inform
Shah M, Moon SU, Choi JH, Kim MJ, Woo HG.   +4 more
europepmc   +1 more source

Bemnifosbuvir: An HCV NS5B Inhibitor With Multiple Modes of Action

Clinical Pharmacology &Therapeutics, EarlyView.
Bemnifosbuvir (BEM) is a potent, pan‐genotypic inhibitor targeting the hepatitis C virus (HCV) NS5B polymerase. Its antiviral activity was evaluated in an ascending dose phase I clinical trial involving 30 patients treated once a day for 7 days. After treatment initiation, plasma HCV RNA declined in a biphasic manner with a mean reduction of 2.3 log10 ...
Carolin Zitzmann, Ruy M. Ribeiro, Aurélien Marc, Xiao‐Jian Zhou, Alan S. Perelson   +4 more
wiley   +1 more source

Rare Extrahepatic Metastasis of Hepatocellular Carcinoma to the Left Triangular Ligament: A Case Report. [PDF]

Surg Case Rep
Tsuda A, Hanaki T, Ishii H, Uehira K, Yoshida J, Kishino M, Morimoto M, Murakami Y, Tokuyasu N, Sakamoto T, Fujiwara Y.   +10 more
europepmc   +1 more source

Integrated care is necessary, but not sufficient, for equity in hepatocellular carcinoma outcomes. [PDF]

Liver Transpl
Hatipoglu D, Mahmud N.
europepmc   +1 more source

Integrating diagnosis and therapy in hepatocellular carcinoma: advances in nanotheranostics. [PDF]

Front Bioeng Biotechnol
Shen J, Wen Y, Wu S, Tian W.
europepmc   +1 more source

Spontaneous rupture of hepatocellular carcinoma: mechanobiology, rescue, and oncologic control. [PDF]

J Gastrointest Oncol
Yu J, Shelat VG.
europepmc   +1 more source